PharmaTher Holdings Ltd (TSE:PHRM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PharmaTher Holdings Ltd. has updated investors on the progress of its FDA New Drug Application for Ketamine, with a GDUFA goal date set for October 29, 2024. The FDA has indicated that no additional information is currently needed. The company is also planning for international approvals and novel uses of ketamine, addressing both the U.S. shortage and global medical needs.
For further insights into TSE:PHRM stock, check out TipRanks’ Stock Analysis page.
